Matthew Paul Kowalsky's Net Worth

$41.2 Thousand

Estimate Recalculated Jul 18, 2024 03:07PM EST

Who is Matthew Paul Kowalsky?

Matthew Paul Kowalsky does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include PROTEON THERAPEUTICS INC, and Sigilon Therapeutics, Inc..

SEC CIK

Matthew Paul Kowalsky's CIK is 0001705824

Past Insider Trading and Trends

2018 was Matthew Paul Kowalsky's most active year for acquiring shares with 3 total transactions. Matthew Paul Kowalsky's most active month to acquire stocks was the month of December. 2023 was Matthew Paul Kowalsky's most active year for disposing of shares, totalling 2 transactions. Matthew Paul Kowalsky's most active month to dispose stocks was the month of July. 2018 saw Matthew Paul Kowalsky paying a total of $20,874.64 for 122,448 shares, this is the most they've acquired in one year. In 2023 Matthew Paul Kowalsky cashed out on 14,615 shares for a total of $9,517.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PROTEON THERAPEUTICS INC (TARA) Snapshot price: $2.72

VP, Legal and Secretary

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 18
Form 4
+9.06%
2.45K
$1.93
$4,724.64
29.48K
Dec 31
Form 4
+58.72%
10K
$1.62
$16,150.00
27.03K
Jun 29
Form 4
—
0
—
—
0
Jan 17
Form 4
+30.04%
3.93K
$1.30
$5,098.46
17.03K
Dec 29
Form 4
+322.89%
10K
$1.30
$12,960.00
13.1K
Jun 30
Form 3
—
0
—
—
0
No matching records found

Sigilon Therapeutics, Inc. No price found

CHIEF OF STAFF AND CLO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.93K
—
—
0
Aug 11
Form 4
—
0
—
—
0
Feb 28
Form 3
—
0
—
—
0
No matching records found

ENANTA PHARMACEUTICALS INC (ENTA) No price found

Chief Legal Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 29
Form 3
—
0
—
—
0
No matching records found